False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors

Transfusion

Volumn 36, Issue 1, 1996, Pages 45-52

  Sayre, K R ^a   Dodd, R Y ^b   Tegtmeier, G ^c   Layug, L ^b   Alexander, S S ^d   Busch, M P ^e,f  

^a Ortho McNeil Pharmaceutical Incorporated   (United States)

^b AMERICAN RED CROSS   (United States)

^c Division of New York Blood Center Enterprises   (United States)

^d Hepatitis Research and Development   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Blood Centers of the Pacific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; EPITOPE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; VIRUS ENVELOPE PROTEIN;

ARTICLE; BLOOD DONOR; CASE REPORT; DIAGNOSTIC ERROR; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; MALE; POLYMERASE CHAIN REACTION;

EID: 0030022251     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36196190514.x     Document Type: Article

References (39)

1. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989;38(Suppl 7):1-7.
2. Interpretive criteria used to report Western blot results for HIV-1-antibody testing - United States. MMWR Morb Mortal Wkly Rep 1991;40:692-5.
3. O'Gorman MR, Weber D, Landis SE, et al. Interpretive criteria of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infection. Arch Pathol Lab Med 1991;115:26-30.
4. Revised recommendations for the prevention of human immunodeficiency virus (HIV) transmission by blood and blood products. Bethesda: Center for Biologies Evaluation and Research, Food and Drug Administration, April 23, 1993
5. Zaaijer HL, van Exel-Oehlers P, Kraaijeveld T, et al. Early detection of antibodies to HIV-1 by third-generation assays. Lancet 1992;340:770-2.
6. Gallarda JL, Henrard DR, Liu D, et al. Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody. J Clin Microbiol 1992;30:2379-84.
7. Saah AJ, Farzadegan H, Fox R, et al. Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol 1987;25:1605-10.
8. Courouce AM. Following up indeterminate HIV-1 western blots (letter). Lancet 1989;2.1330-1.
9. King R, Frey S, Beisha R, et al. The presence or absence of gp120/gp160 bands on indeterminate western blots: predictive value for HIV seroconversion (letter). AIDS 1993;7:437-8.
10. Read S, Cassol S, Coates R, et al. Detection of incident HIV infection by PCR compared to serology. J Acquir Immune Defic Syndr 1992;5:1075-9.
11. Dock NL, Lamberson HV Jr, O'Brien TA, et al. Evaluation of atypical human immunodeficiency virus immunoblot reactivity in blood donors. Transfusion 1988;28:412-8.
12. Nusbacher J, Naiman R. Longitudinal follow-up of blood donors found to be reactive for antibody to human immunodeficiency virus (anti-HIV) by enzyme-linked immunoassay (EIA+) but negative by western blot (WB-). Transfusion 1989;29:365-7.
13. Genesca J, Shih JWK, Jett BW, et al. What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors? Lancet 1989;2:1023-5.
14. Jackson JB, MacDonald KL, Cadwell J, et al. Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1. N Engl J Med 1990;322:217-22.
15. Dock NL, Kleinman SH, Rayfield MA, et al. Human immunodeficiency virus infection and indeterminate western blot patterns. Prospective studies in a low prevalence population. Arch Intern Med 1991;151:525-39.
16. Celum CL, Coombs RW, Lafferty W, et al. Indeterminate human immunodeficiency virus type 1 western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation. J Infect Dis 1991;164:656-64.
17. Eble BE, Busch MP, Khayam-Bashi H, et al. Resolution of infection status of human immunodeficiency virus (HIV)-seroindeterminate and high-risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high-prevalence area. Transfusion 1992;32:503-8.
18. Phair J, Hoover D, Huprikar J, et al. The significance of western blot assays indeterminate for antibody to HIV in a cohort of homosexual/bisexual men. The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1992;5:988-92.
19. Hunter JB, Menitove JE. HLA antibodies detected by ELISA HTLV-III antibody kits (letter). Lancet 1985;2:397.
20. Ameglia F, Dolei A, Benedetto A, et al. Antibodies reactive with nonpolymorphic epitopes on HLA molecules interfere in screening tests for the human immunodeficiency virus (letter). J Infect Dis 1987;156:1034-5.
21. Blanton M, Balakrishnan K, Dumaswala U, et al. HLA antibodies in blood donors with reactive screening tests for antibody to the immunodeficiency virus (letter). Transfusion 1987;27:118-9.
22. Povolotsky J, Gold JWM, Chein N, et al. Differences in human immunodeficiency virus type 1 (HIV-1) anti-p24 reactivities in serum of HIV-1-infected and uninfected subjects: analysis of indeterminate western blot reactions. J Infect Dis 1991;163:247-51.
23. Whetstone CA, Sayre KR, Dock NL, et al. Examination of whether persistently indeterminate human immunodeficiency virus type 1 Western immunoblot reactions are due to serological reactivity with bovine immunodeficiency-like virus. J Clin Microbiol 1992;30:764-70.
24. Langedijk JP, Vos WF, van Doornum GJ, et al. Identification of cross-reactive epitopes recognized by HIV-1 false-positive sera (letter). AIDS 1992;6:1547-8.
25. Jindal R, Solomon M, Burrows L. False positive tests for HIV in a woman with lupus and renal failure (letter). N Engl J Med 1993;328:1281-2.
26. Healey DS, Bolton WV. Apparent HIV-1 glycoprotein reactivity on western blot in uninfected blood donors. AIDS 1993;7:655-8.
27. Ratner L, Haseltine W, Patarca R, et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985;313:277-84.
28. Busch MP, El Amad Z, McHugh TM, et al. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay. Transfusion 1991;31.129-37.
29. McNairn D, Kline R, Quinn TC. Evaluation of the Chiron® RIBA™ HIV-1/HIV-2 Strip Immunoblol Assay (SIA) (abstract 370). Presented at the Second National Conference on Human Retroviruses, Washington DC, Jan-Feb 1995:122.
30. Pinter A, Honnen WJ, Tilley SA, et al. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J Virol 1989;63:2674-9.
31. Earl PL, Doms RW, Moss B. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci U S A 1990;87:648-52.
32. Ascher DP, Roberts C. Determination of the etiology of seroreversals in HIV testing by antibody fingerprinting. J Acquir Immune Defic Syndr 1993;6:241-4.
33. Sabino EC, Delwart E, Lee TH, et al. Identification of low-level contamination of blood as basis for detection of human immunodeficiency virus (HIV) DNA in anti-HIV-negative specimens. J Acquir Immune Defic Syndr 1994;7:853-9.
34. Association of State and Territorial Public Health Laboratory Directors. Presented at the 8th Annual Conference on Human Retrovirus Testing, Reno, NV, 1993:2
35. Bukrinsky MI, Chaplinskas SA, Syrtsev VA, et al. Reactivity to gag- and env-related proteins in immunoblot assay is not necessarily indicative of HIV infection (letter). AIDS 1988;2:405-6.
36. env. Should criteria for seropositivity be revised? (letter). AIDS 1991;5:770.
37. Gonzalez-Scarano F, Waxham MN, Ross AM, Hoxie JA. Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. AIDS Res Hum Retroviruses 1987;3:245-52.
38. Tomiyama T, Lake D, Masuho Y, Hersh EM. Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum. Biochem Biophys Res Commun 1991;177:279-85.
39. Wu AF, Wood C, Wu TT. Possibility of HIV gp41 and thymosin beta-4 sharing the same antigenic epitope (letter). AIDS 1989;3:319-20.